Because LATE-NC co-occurs in most clinical AD cases alongside Aβ plaques and tau NFTs [3, 7] (Fig. 5), this study has an impact in the understanding of TDP-43 pathogenesis in AD and LATE, which account for the majority of dementia cases worldwide [2, 6, 80]. The gene discussed is MAPT; the disease is Alzheimer disease.